⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDWD News
MediWound Ltd.
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
globenewswire.com
MDWD
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
MDWD
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
MDWD
MediWound to Report Second Quarter 2026 Financial Results
globenewswire.com
MDWD
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
MDWD
Nexobrid (MediWound) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
MDWD
MediWound to Report First Quarter 2026 Financial Results
globenewswire.com
MDWD
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
globenewswire.com
MDWD
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
globenewswire.com
MDWD
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
globenewswire.com
VCEL
MDWD